UNII 506T60A25R

SORBITOL

Unique Ingredient Identifier 506T60A25R is listed as a ingredient substance
RN50-70-4
EC200-061-5
NCITC29462
RXCUI9945
PUBCHEM5780
MFC6H14O6
INCHI KEYFBPFZTCFMRRESA-JGWLITMVSA-N
SMILESOC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

Alternate Names

Dosage Forms

UNII 506T60A25R SORBITOL is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALGUM, CHEWING257 MG
DENTALPASTE NA
INTRA-ARTICULARINJECTION84.83 %
INTRALESIONALINJECTION45 %
INTRAMUSCULARINJECTION84.83 %
INTRASYNOVIALINJECTION84.83 %
INTRAVENOUSINJECTION45 MG/1ML
INTRAVENOUSINJECTION30 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED5.43 %
INTRAVENOUSSOLUTION, INJECTION48 %
IV(INFUSION)INJECTABLE4.7 %
IV(INFUSION)INJECTION30 %
IV(INFUSION)SOLUTION, INJECTION7.14 %
NASALSOLUTION2.5 %
NASALSPRAY6165 MCG/SPRAY
NASALSPRAY4.55 %
NASALSPRAY, METERED6.45 %
OPHTHALMICSOLUTION4.6 %
OPHTHALMICSOLUTION, DROPS0.25 %
ORALBAR, CHEWABLE NA
ORALCAPSULE185.18 MG
ORALCAPSULE, SOFT GELATIN113.6 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED NA
ORALCONCENTRATE400 MG/1ML
ORALDROPS30 MG/1ML
ORALGRANULE, FOR SUSPENSION28 MG
ORALGUM, CHEWING257 MG
ORALLIQUID286 MG/5ML
ORALPOWDER11.147 MG/BOTTLE
ORALPOWDER5 %
ORALPOWDER, FOR SUSPENSION342.84 MG/1ML
ORALPOWDER, FOR SUSPENSION0.15 g/236mL
ORALSOLUTION335 MG/5ML
ORALSOLUTION, ELIXIR33 %
ORALSOLUTION, LIQUID0.005 %V/V
ORALSUSPENSION184.14 MG/1ML
ORALSUSPENSION, LIQUID2000 MG/5ML
ORALSYRUP71.2 %
ORALTABLET337.28 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE316 MG
ORALTABLET, COATED12.96 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED NA
ORALTABLET, EXTENDED RELEASE47.4 MG
ORALTABLET, FILM COATED5 MG
ORALTABLET, ORALLY DISINTEGRATING7 MG
ORALTABLET, SUSTAINED ACTION53.75 MG
RECTALSUSPENSION33.33 %
SUBCUTANEOUSINJECTABLE4.7 %
SUBCUTANEOUSSOLUTION, INJECTION4.7 %
SUBLINGUALTABLET50.5 MG
TOPICALCREAM10 %W/W
TOPICALEMULSION7 %W/W
TOPICALEMULSION, CREAM5 %W/W
TOPICALLIQUID9.6 %W/W
TOPICALLOTION NA
TOPICALOINTMENT10 %W/W
TOPICALSOLUTION4.6 %W/V
VAGINALINSERT55.1 MG
VAGINALTABLET NA
BUCCALGUM, CHEWING45 MG
INTRA-ARTICULARINJECTION84.83 %
INTRALESIONALINJECTION NA
INTRAMUSCULARINJECTION84.83 %
INTRASYNOVIALINJECTION84.83 %
INTRAVENOUSINJECTION7.14 %
INTRAVENOUSSOLUTION, INJECTION7.14 %
IV(INFUSION)SOLUTION, INJECTION7.14 %
NASALSPRAY, METERED8836.5 MCG/SPRAY
NASALSPRAY, METERED0.006 %
OPHTHALMICSOLUTION6.7 %
ORALCAPSULE95 MG
ORALCAPSULE, COATED, SOFT GELATIN3.11 MG
ORALCAPSULE, SOFT GELATIN80 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED97 MG
ORALCONCENTRATE600 MG/1ML
ORALDROPS50 MG/1ML
ORALGUM, CHEWING45 MG
ORALLIQUID2970 MG/5ML
ORALORAL SOLUTION DOSAGE FORM1350 mg/5mL
ORALSOLUTION2142.83 MG/5ML
ORALSOLUTION, CONCENTRATE300 MG/1ML
ORALSOLUTION, ELIXIR75 %
ORALSOLUTION, SYRUP500 MG/1ML
ORALSUSPENSION4012.5 MG/15ML
ORALSUSPENSION3570 MG/5ML
ORALSUSPENSION571.43 mg/1mL
ORALSUSPENSION62.5 mg/1.25mL
ORALSUSPENSION, DROPS250 MG/1ML
ORALSUSPENSION, LIQUID2000 MG/5ML
ORALSUSPENSION, SYRUP, SUSTAINED ACTION2 %
ORALSYRUP4370 MG/5ML
ORALTABLET14 MG
RECTALSUSPENSION46.18 %
TOPICALCREAM17.5 MG/1G
TOPICALCREAM13.5 %W/W
TOPICALCREAM, AUGMENTED15 %W/W
TOPICALCREAM, EMULSION, SUSTAINED RELEASE36.8 %W/W
TOPICALEMULSION, CREAM25 %W/W
TOPICALFILM, CONTROLLED RELEASE2800 MG
TOPICALLOTION5 %W/W
TOPICALOINTMENT1.5 %W/W
TOPICALPATCH2240 MG
TOPICALPATCH, CONTROLLED RELEASE NA
TOPICALSOLUTION, DROPS6.9 %W/V
VAGINALCREAM, EMULSION, SUSTAINED RELEASE36.8 %W/W
VAGINALEMULSION, CREAM36.8 %

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.